National Academies of Science, Engineering, and Medicine (Virtual)
February 22, 2021
twoXAR Pharmaceuticals CEO Andrew A. Radin presents in a session on new technologies enabling discovery research.
EPPIC Global (Digital)
October 17, 2020
twoXAR Pharmaceuticals SVP Nonclinical R&D & Chemistry Anjali Pandey moderates a panel including twoXAR CEO Andrew Radin, along with representatives from Recursion Pharma, ATOM Consortium, and NuMedii.
MIT ILP (Digital)
October 16, 2020
twoXAR Pharmaceuticals CEO Andrew Radin presents on the company's capabilities in discovering first-in-class small molecules for oncology and more using AI.
Andrew A. Radin, CEO - TEDMED 2016
WEBINARS, PODCASTS & VIDEOS